Description
Conformis, Inc., branded as Conformis, is a global medical device company, publicly traded on the NASDAQ (NASDAQ: CFMS). Founded in 2004 by Dr. Phillipp Lang, Conformis primarily designs and manufactures patient-specific knee and hip replacement implants for orthopaedic patients. The implants are used by surgeons to treat osteoarthritis.
Headquartered in Billerica, Massachusetts, Conformis uses its proprietary iFit Image-to-Implant technology to manufacture and sell patient-specific implants and instruments. Conformis is best known for developing individualized prostheses, and offers related services for the orthopaedic medical industry. The company’s technology has been implanted in more than 100,000 patients and continues to make notable advancements for the medical field. In the United States and internationally, Conformis' products are sold directly to doctors, hospitals, and other healthcare facilities.
Conformis technology is designed for a minimally invasive procedure that is unique for every patient by incorporating imaging technology in both the design and surgical planning processes. The company has also received several awards for its innovative products.
